drugset / Trial / NCT00958243
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety profile of CSL425 (CSL's 2009 H1N1 influenza vaccine) in a healthy pediatric population.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-11
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSL425 | Vaccine | 7.5 ug | Intramuscular |
| Subject | CSL425 | Vaccine | 15 ug | Intramuscular |